FDAnews
www.fdanews.com/articles/120436-migraine-study-does-not-meet-primary-endpoint

Migraine Study Does Not Meet Primary Endpoint

September 14, 2009
Alexza Pharmaceuticals, Inc. announced preliminary results from its 366 patient Phase IIb clinical trial of AZ-104 in patients with migraine headache.
StreetInsider